CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC bought $501K of Corvus Pharmaceuticals, Inc.
Director and 10% owner
Bought$500,723
$3.51Price
142,656Shares
+2%Stake
What CRVS did for a copier
Prices for CRVS after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Aug 6. Filed Thu, Aug 8, 4:59 PM ET, after the close. Not investment advice.